Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers.
Xu H, Yan M, Patra J, Natrajan R, Yan Y, Swagemakers S, Tomaszewski JM, Verschoor S, Millar EK, van der Spek P, Reis-Filho JS, Ramsay RG, O'Toole SA, McNeil CM, Sutherland RL, McKay MJ, Fox SB.
Xu H, et al. Among authors: yan m, yan y.
Breast Cancer Res. 2011 Jan 21;13(1):R9. doi: 10.1186/bcr2814.
Breast Cancer Res. 2011.
PMID: 21255398
Free PMC article.